INJECTION SCLEROTHERAPY IN THE TREATMENT OF RECTAL PROLAPSE IN INFANTS AND CHILDREN

Citation
Wky. Chan et al., INJECTION SCLEROTHERAPY IN THE TREATMENT OF RECTAL PROLAPSE IN INFANTS AND CHILDREN, Journal of pediatric surgery, 33(2), 1998, pp. 255-257
Citations number
6
Categorie Soggetti
Pediatrics,Surgery
ISSN journal
00223468
Volume
33
Issue
2
Year of publication
1998
Pages
255 - 257
Database
ISI
SICI code
0022-3468(1998)33:2<255:ISITTO>2.0.ZU;2-K
Abstract
Purpose: The aim of this study was to examine the efficacy of injectio n sclerotherapy as treatment for persistent rectal prolapse. Methods: The records of 28 patients with rectal prolapse treated with injection sclerotherapy over a 16-year period were reviewed. Initial management included assessment and correction of predisposing factors. If rectal prolapse persisted or if the prolapse required repeat emergency or op erating room reduction, injection sclerotherapy was performed. The scl erosing agent included D50W in 21 patients (sole agent in 15, combined with ethanolamine oleate in four, and with phenol 5% in two). Phenol 5% alone was used in six patients, and 25% saline was used in one pati ent. Number of injections, recurrences, and complications were reviewe d. Results: Two patients were lost to follow-up, and one patient was c ured once a polyp was recognized and removed. Of the remaining 25 pati ents, 21 were cured. Sixteen required one injection, three required tw o injections, and two required three injections (64% cure rate after o ne injection, 84% cure rate after three injections). There were 4 of 2 5 failures: two went on to low anterior resection after having failed two injections each; one patient was treated with Thiersch cerclage an d injection after two failed injections; and one patient did not respo nd after three injections but had less severe prolapses. Of those inje cted with D50W alone, 13 of 14 were cured with injection sclerotherapy . Nine received one injection, two received two injections, and two re ceived three injections (64% cure rate after one injection, 93% cure r ate after three injections). The only complication was excessive oozin g at the injection site in one patient. He was simply observed in hosp ital overnight. Follow-up averaged 33 months. The only significant und erlying abnormality in our patient population was spina bifida in one patient. This patient was cured with injection therapy. Cystic fibrosi s was ruled out by clinical examination and sweat chloride test in all patients. Constipation was the most common condition identified with the onset of rectal prolapse (15 of 28). Conclusions: Injection sclero therapy is simple and should be considered as the first line treatment of recurrent rectal prolapse after failure of conservative measures. D50W is effective, easily available, inexpensive, and associated with few complications. Copyright (C) 1998 by W.B. Saunders Company.